Recombinant Uncharacterized protein Rv0879c/MT0902 (Rv0879c, MT0902)

Shipped with Ice Packs
In Stock

Description

Functional Hypotheses

Though uncharacterized, insights from related mycobacterial proteins suggest potential roles:

  • Stress Response: Redox-regulated chaperones like Rv0991c (Ruc) in M. tuberculosis stabilize proteins during oxidative stress . While no direct evidence links Rv0879c to chaperone activity, its recombinant production for structural studies implies interest in stress-related pathways .

  • Immunogenicity: Unique M. tuberculosis proteins (e.g., Rv1509) elicit strong Th1 immune responses . Rv0879c’s exclusivity to M. tuberculosis raises speculation about its role in host-pathogen interactions .

B. Key Limitations

  • No peer-reviewed studies directly investigate its biochemical function.

  • Functional annotations rely on computational predictions or analogies to homologous proteins .

Comparative Analysis with Other Uncharacterized Proteins

ProteinFunctionSignificance in M. tuberculosisReference
Rv0991c (Ruc)Redox-regulated chaperoneProtects against oxidative proteotoxicity
Rv1509Elicits Th1 immune responseVaccine candidate
Rv0879cUndeterminedUnique to M. tuberculosis

Future Research Directions

  1. Structural Studies: Resolving its 3D structure could reveal binding pockets or motifs.

  2. Knockout Models: Assessing virulence changes in M. tuberculosis lacking Rv0879c.

  3. Immune Profiling: Testing its ability to activate human T cells or antibodies .

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Contact your local distributor for precise delivery estimates.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors: storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C; lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-91
Protein Length
full length protein
Target Names
Rv0879c, MT0902
Target Protein Sequence
MSVENSQIREPPPLPPVLLEVWPVIAVGALAWLVAAVAAFVVPGLASWRPVTVAGLATGL LGTTIFVWQLAAARRGARGAQAGLETYLDPK
Uniprot No.

Q&A

What is Rv0879c/MT0902 and what is currently known about its function?

Rv0879c/MT0902 is an uncharacterized protein from Mycobacterium tuberculosis, the causative agent of tuberculosis. Despite being identified in the M. tuberculosis genome, its precise function remains largely unknown . The protein consists of 91 amino acids in its primary sequence and is classified as "uncharacterized" because its biochemical activity, cellular localization, and role in M. tuberculosis physiology or pathogenesis have not been fully elucidated.

To begin characterizing this protein, researchers typically employ sequence analysis tools to identify conserved domains, homology to proteins of known function, and potential structural motifs. Methods include:

  • Sequence alignment with homologous proteins from related species

  • Protein family database searches

  • Secondary structure prediction

  • Signal peptide and transmembrane domain analysis

  • Post-translational modification site prediction

The systematic approach to functional prediction requires combining computational predictions with experimental validation through techniques like gene knockout/knockdown studies, protein-protein interaction assays, and gene expression analysis under different growth conditions.

What expression systems are optimal for producing recombinant Rv0879c/MT0902 protein?

Multiple expression systems can be used to produce recombinant Rv0879c/MT0902, with each offering distinct advantages depending on research objectives . The comparison table below summarizes key considerations:

Expression SystemAdvantagesLimitationsOptimal Applications
E. coliHigh yield, rapid production, cost-effective, established protocolsLimited post-translational modifications, potential inclusion body formationInitial characterization, antibody production, high-throughput screening
YeastModerate to high yield, eukaryotic post-translational modifications, secretion possibleLonger production time than E. coli, hyperglycosylation possibleStructural studies requiring some post-translational modifications
Baculovirus/Insect cellsComplex eukaryotic post-translational modifications, proper folding of complex proteinsLower yield, higher cost, longer production timeFunctional studies requiring authentic protein modifications
Mammalian cellsMost authentic post-translational modifications, highest likelihood of proper foldingLowest yield, highest cost, longest production timeStudies focusing on protein-protein interactions, enzymatic activity

How should I design experiments to characterize an uncharacterized protein like Rv0879c?

When designing experiments to characterize uncharacterized proteins like Rv0879c, a systematic approach following the principles of sound experimental design is essential . The experimental design should progress through these stages:

Especially important for uncharacterized proteins is the iterative nature of the experimental design. Initial results should inform subsequent experiments, gradually building a comprehensive understanding of the protein's characteristics and function through complementary approaches.

What are the best methods for studying protein-protein interactions involving Rv0879c?

To investigate potential protein-protein interactions involving Rv0879c, researchers should employ multiple complementary techniques to validate interactions and minimize false positives:

  • In vitro methods:

    • Pull-down assays using purified recombinant Rv0879c as bait

    • Surface Plasmon Resonance (SPR) to measure binding kinetics

    • Isothermal Titration Calorimetry (ITC) for thermodynamic parameters

    • Size Exclusion Chromatography combined with Multi-Angle Light Scattering (SEC-MALS)

  • Cell-based methods:

    • Yeast two-hybrid screening against M. tuberculosis proteome

    • Bacterial two-hybrid systems (more suitable for prokaryotic proteins)

    • Co-immunoprecipitation from M. tuberculosis lysates

    • Proximity-based labeling methods (BioID, APEX)

  • Computational prediction:

    • Interactome prediction based on genomic context

    • Co-expression analysis from transcriptomic data

    • Structural docking simulations

  • Validation strategies:

    • Confirming interactions by at least two independent methods

    • Demonstrating biological relevance through functional assays

    • Performing domain mapping to identify specific interaction regions

When designing these experiments, it's crucial to include appropriate controls and to consider the native cellular environment of Rv0879c in M. tuberculosis, as interactions may depend on specific conditions found in the bacterium during infection.

How can structural studies of Rv0879c/MT0902 contribute to understanding its function?

Structural studies of Rv0879c can provide critical insights into its potential function through:

  • X-ray crystallography approach:

    • Express and purify Rv0879c with high homogeneity (>95% purity)

    • Screen multiple crystallization conditions (pH, salt, temperature)

    • Obtain diffraction data and solve the structure

    • Identify structural motifs that suggest function

  • NMR spectroscopy for solution structure:

    • Particularly useful for smaller proteins like Rv0879c (91 aa)

    • Requires isotope labeling (¹⁵N, ¹³C) during recombinant expression

    • Provides dynamics information not available from crystal structures

  • Cryo-electron microscopy:

    • Useful if Rv0879c forms larger complexes

    • May reveal contextual information about protein interactions

  • Structural bioinformatics analysis:

    • Comparing solved structure to known functional domains

    • Identifying potential ligand binding pockets

    • Electrostatic surface mapping to predict interaction interfaces

The structural data obtained can then guide functional hypotheses by revealing:

  • Catalytic sites suggesting enzymatic function

  • Binding pockets indicating potential for small molecule interactions

  • Structural similarity to proteins of known function

  • Surface properties that might explain localization or interaction potential

What approaches should be used to investigate Rv0879c's potential role in M. tuberculosis drug resistance?

Given that M. tuberculosis is prone to developing drug resistance , investigating Rv0879c's potential role in this phenomenon requires a multifaceted approach:

  • Gene expression analysis:

    • Compare Rv0879c expression levels between drug-sensitive and resistant strains

    • Analyze expression changes in response to antibiotic exposure

    • Use RNA-seq and qRT-PCR to quantify expression differences

  • Genetic manipulation studies:

    • Create Rv0879c knockout or knockdown M. tuberculosis strains

    • Test antibiotic susceptibility profiles compared to wild-type

    • Complement mutant strains to confirm phenotype specificity

    • Create overexpression strains to test for increased resistance

  • Biochemical interaction studies:

    • Test direct binding between purified Rv0879c and antibiotics

    • Investigate potential enzymatic activities that could modify antibiotics

    • Examine interactions with known drug resistance proteins

  • Structural basis of resistance:

    • If Rv0879c is involved in resistance, solve structures of protein-drug complexes

    • Identify potential resistance-conferring mutations through structural analysis

    • Use molecular dynamics simulations to predict resistance mechanisms

  • Clinical correlation studies:

    • Sequence Rv0879c in clinical isolates with varying drug resistance profiles

    • Correlate mutations with resistance patterns

    • Validate findings through in vitro susceptibility testing

A comprehensive experimental design would progress systematically from correlation (expression studies) to causation (genetic manipulation) to mechanism (biochemical and structural studies), ultimately seeking clinical relevance.

How should I approach contradictory results when characterizing Rv0879c/MT0902?

When facing contradictory results in Rv0879c characterization studies, a systematic troubleshooting approach is essential:

  • Data verification steps:

    • Re-check raw data and calculations for potential errors

    • Verify reagent quality and experimental conditions

    • Repeat experiments with increased technical and biological replicates

    • Have colleagues independently verify critical results

  • Methodological considerations:

    • Different expression systems may yield proteins with varying properties

    • Protein tags can influence folding, activity, or interaction potential

    • Buffer conditions may affect protein behavior

  • Reconciliation strategies:

    • Design experiments that directly address the contradiction

    • Consider whether contradictions reflect different aspects of a complex function

    • Implement orthogonal techniques to validate findings

  • Manuscript preparation approach:

    • Transparently report contradictory findings

    • Discuss potential explanations for discrepancies

    • Acknowledge limitations and propose further validation studies

When responding to reviewers about contradictory results, be thorough in explaining your reanalysis process, provide evidence of comprehensive verification, and demonstrate additional validation steps taken . Remember that contradictions often lead to deeper understanding when properly investigated.

What statistical approaches are most appropriate for analyzing data from Rv0879c functional studies?

  • Exploratory data analysis:

    • Begin with descriptive statistics and data visualization

    • Check for normal distribution using Shapiro-Wilk or Kolmogorov-Smirnov tests

    • Identify potential outliers and assess their biological significance

  • Hypothesis testing frameworks:

    • For comparing two conditions (e.g., wildtype vs. mutant):

      • Student's t-test (parametric) or Mann-Whitney U test (non-parametric)

    • For multiple conditions:

      • ANOVA with post-hoc tests (parametric)

      • Kruskal-Wallis with post-hoc tests (non-parametric)

  • Correlation analyses:

    • Pearson correlation (linear, parametric)

    • Spearman correlation (rank-based, non-parametric)

    • Multiple regression for complex relationships

  • Advanced statistical approaches:

    • Principal Component Analysis for multivariate data

    • Hierarchical clustering for identifying related conditions

    • Machine learning approaches for complex pattern recognition

  • Statistical power considerations:

    • Calculate minimum sample sizes required for adequate power

    • Report effect sizes alongside p-values

    • Consider biological vs. statistical significance

A robust statistical approach should include:

  • Pre-registration of analysis plans when possible

  • Transparent reporting of all statistical tests performed

  • Appropriate correction for multiple comparisons

  • Validation using independent datasets when available

How should I address major revisions when reviewers question my analysis of Rv0879c data?

When addressing major revisions related to Rv0879c research, especially when reviewers question your data analysis:

  • Response strategy:

    • Thoroughly recheck your raw data and analysis workflows

    • Acknowledge mistakes transparently if found

    • Perform comprehensive verification of all calculations

    • Have colleagues independently verify your analysis

  • Revision preparation:

    • Clean and organize your data analysis scripts

    • Create clear documentation of analytical methods

    • Prepare supplementary materials showing step-by-step analysis

    • Consider sharing raw data if permitted

  • Reviewer communication:

    • Express gratitude for identifying issues

    • Clearly explain corrections and verification processes

    • Address how you've ensured accuracy in other analyses

    • Be specific about changes made to the manuscript

  • Additional validation:

    • Consider additional experiments to confirm key findings

    • Implement alternative analytical approaches

    • Include sensitivity analyses to demonstrate result robustness

    • Update framing if results have changed substantially

When researchers discover calculation errors during revision, editors and reviewers typically appreciate honesty and thoroughness in correction rather than viewing it as disqualifying . The most important factor is demonstrating scientific integrity through transparent reporting and comprehensive verification of remaining analyses.

What resources are available to assist with ChatGPT integration in Rv0879c research?

While conducting research on uncharacterized proteins like Rv0879c, AI tools such as ChatGPT can support various research activities:

  • Literature review assistance:

    • Summarizing research papers related to Rv0879c or similar proteins

    • Identifying connections between disparate findings

    • Generating research questions based on knowledge gaps

  • Experimental design support:

    • Suggesting control variables and experimental conditions

    • Helping formulate testable hypotheses

    • Providing methodological recommendations

  • Data analysis assistance:

    • Suggesting appropriate statistical approaches

    • Helping with interpretation of complex results

    • Generating code snippets for analysis workflows

  • Manuscript preparation:

    • Assisting with clear explanation of methods

    • Suggesting structure for discussion sections

    • Helping address reviewer comments effectively

  • All AI-generated content requires expert verification

  • Citations and factual claims must be independently checked

  • The tool should supplement rather than replace expert judgment

  • All use of AI assistance should be transparently acknowledged

A practical approach involves using ChatGPT as a brainstorming partner or draft generator, followed by rigorous review and refinement by domain experts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.